Search results

Technologies 1

• CogniXense: A Platform for Rapid Drug Repurposing
  CogniXense is a target-agnostic drug discovery platform that enables the repurposing of drugs for rare genetic diseases in record time. By combining human data-based computational drug prediction with on-demand animal model development, we can mimic the diversity of symptoms of patient populations and begin drug screening on new diseases within a month.

News 11

View all

• Community
  
  How tadpoles can help cure rare genetic diseases
  October 20, 2020
• Press Release
  
  A reliable clock for your microbiome
  October 11, 2019
• Research Spotlights
  
  Light shed on century-old riddle of chromosome pairing
  October 4, 2019

Multimedia 1

• 

  Video/Animation
  CogniXense: Speeding Up Treatments for Rare Diseases
  At the Wyss Institute, we are tackling Rett syndrome, a rare disease that affects 1 out of 9,000 children, by developing a scalable model for neurodevelopmental and cognitive diseases. This model can test drugs to see which will improve memory, learning, and behavior, with the end goal of finding effective therapies. Credit: Wyss Institute at...